{"link": "http://hdl.handle.net/10138/45067", "subject": "biokemia', 'biokemia", "wordcount": 17964, "major": "Glycobiological insights in characterization and targeting of umbilical cord blood derived stem cells", "abstract": "Stem cells have a unique ability to both self-renew and differentiate into diverse cell types and they harbor remarkable potential in therapeutic applications. Stem cells can be isolated from various sources of both embryonic and adult origin. During the past decade, research on stem cells has rapidly expanded, but many issues of stem cell biology and their clinical use remain unresolved. There is a need for methods to thoroughly characterize therapeutic cell populations, to better distinguish them from other cells, and to control variation within and between different cell preparations. \\n\\nThe surface of stem cells, like all other human cell surfaces, is covered by a complex network of glycans. This is the outmost layer of cells, called the glycocalyx. The glycocalyx is characteristic to and different in every cell type and reflects even subtle changes in cell behaviour and for example cell differentiation. Cell surface glycans are the first cellular components encountered by approaching cells, pathogens, signalling molecules and other binders, making the terminal glycan units key players in cell interactions and signalling. Due to their prominent cell surface localization, glycan epitopes can be utilized for identifying and isolating specific cell types from heterogeneous populations. \\n\\nThe aim of this study was to characterize relevant glycan structures on umbilical cord blood derived stem and progenitor cells, to study how they are regulated and to determine their influence on stem cell biology. As decribed in the original publications of this study, we were able to characterize two novel glycan determinants, O-GlcNAc and linear poly-LacNAc, on umbilical cord blood derived mesenchymal stromal cells (UCB-MSCs). We further discovered that galectins-1 and -3 secreted by these cells are bound on the cell surface and that the cell surface galectin-1 interacts with P-selectin. This interaction is likely to play a role in the immunomodulatory homing of UCB-MSCs to sites of injury or inflammation. In addition, we present the effects and potential use of metabolic glycoengineering of UCB-MSC. \\n\\nTaken together, these studies provide new insights into the glycobiology of UCB derived stem and progenitor cells. This information may help to distinguish better cell populations for distinct therapeutic applications and to design therapeutic cells with enhanced biological properties.', 'Kantasolut ovat erilaistumattomia soluja, joilla on ainutlaatuinen kyky jakautua ja erilaistua erilaisiksi solutyypeiksi ja edelleen kudoksiksi. Kantasoluista odotetaankin tulevaisuudessa uusia hoitomuotoja moniin vaikeisiin sairauksiin, kuten diabetekseen, Parkinsonin tautiin ja MS tautiin. Kantasoluja on l\u00f6ydetty pieness\u00e4 m\u00e4\u00e4rin l\u00e4hes kaikista elimist\u00f6n eri kudoksista. Erityisen rikkaita kantasolul\u00e4hteit\u00e4 alkion kantasolujen lis\u00e4ksi ovat luuydin ja istukkaveri, joiden kantasolut luokitellaan aikuisen kantasoluiksi. Vaikka kantasoluja on laajasti tutkittu, ei niiden biokemiallisia ominaisuuksia viel\u00e4 t\u00e4ysin ymm\u00e4rret\u00e4. \\n\\nKaikkien solujen pinta on sokerirakenteiden verkoston peitossa. T\u00e4m\u00e4 solun pinnan sokerirakenneverkosto on jokaisella solutyypill\u00e4 erilainen ja sen perusteella voidaan tunnistaa eri solutyyppej\u00e4. Solun pinnan sokerit v\u00e4litt\u00e4v\u00e4t solun vuorovaikutuksia toisien solujen ja solun ymp\u00e4rist\u00f6n kanssa. Solun pinnan sokerit my\u00f6s muuntuvat nopeasti solun tilanteen muuttuessa, esimerkiksi kantasolun erilaistuessa, tai solun vastatessa sen ymp\u00e4rist\u00f6st\u00e4 tulleisiin \u00e4rsykkeisiin. \\n\\nT\u00e4m\u00e4n tutkimuksen tarkoituksena oli kartoittaa istukkaveren kantasolujen pinnan sokerirakenteita, sek\u00e4 tutkia niiden s\u00e4\u00e4telymekanismeja ja merkityst\u00e4 kantasoluille. L\u00f6ysimme istukkaveren mesenkymaalisten kantasolujen pinnalta kaksi uutta sokerirakennetta; O-glykosidisella sidoksella kiinnittyneen N-asetyyliglukosamiinin, sek\u00e4 lineaarisen poly-N-asetyylilaktosamiinin. Havaitsimme my\u00f6s, ett\u00e4 n\u00e4iden solujen pinnalla ilmentyy kaksi t\u00e4rke\u00e4\u00e4 sokerirakenteisiin kiinnittyv\u00e4\u00e4 proteiinia, galektiini-1 ja galektiini-3, jotka voivat kiinnitty\u00e4 l\u00f6ydettyyn poly-N-asetyylilaktosamiinirakenteeseen. N\u00e4iden galektiinien on todettu kuvastavan mesenkymaalisten kantasolujen terapeuttisia ominaisuuksia. Lis\u00e4ksi tutkimuksemme osoitti, ett\u00e4 solun pinnan galektiini-1 sitoutuu P-selektiiniin, joka ohjaa kantasolujen kiinnittymist\u00e4 vaurioituneisiin tai tulehtuneisiin kudoksiin. Tutkimme my\u00f6s miten solun pinnan sokerirakenteiden muokkaus aineenvaihdunnan v\u00e4lityksell\u00e4 vaikuttaa solun ilment\u00e4mien sokeriverkostojen koostumukseen. \\n\\nJotta kantasoluhoitoja voidaan turvallisesti kehitt\u00e4\u00e4, tarvitaan tehokkaita menetelmi\u00e4 n\u00e4iden solujen erist\u00e4miseen ja tunnistamiseen. T\u00e4m\u00e4 tutkimus toi esille uusia lupaavia n\u00e4k\u00f6kulmia kantasolujen biokemiallisista ominaisuuksista ja n\u00e4it\u00e4 tuloksia voidaan hy\u00f6dynt\u00e4\u00e4 tutkittaessa kantasolujen k\u00e4ytt\u00f6\u00e4 erilaisten sairauksien hoidossa.", "faculty": "bioymp", "charcount": 108062, "commonwords": [["cells", 362], ["cell", 353], ["stem", 281], ["et", 276], ["al", 276], ["blood", 113], ["surface", 110], ["expression", 107], ["mesenchymal", 80], ["ucb", 75], ["human", 73], ["cord", 70], ["mscs", 66], ["progenitor", 61], ["glycan", 60], ["ucb-mscs", 59], ["2012", 57], ["figure", 54], ["2013", 54], ["bone", 53]], "keywords": "", "unit": "bio- ja ymp\u00e4rist\u00f6tieteellinen tiedekunta, biotieteiden laitos', 'Helsingfors universitet, bio- och milj\u00f6vetenskapliga fakulteten, biovetenskapliga institutionen', 'University of Helsinki, Faculty of Biological and Environmental Sciences, Department of Biosciences, Biochemistry', 'Finnish Red Cross Blood Service", "status": "doctor", "thesistype": "V\u00e4it\u00f6skirja (artikkeli)', 'Doctoral dissertation (article-based)', 'Doktorsavhandling (sammanl\u00e4ggning)', 'Text", "pagecount": 65, "title": "Glycobiological insights in characterization and targeting of umbilical cord blood derived stem cells", "language": "en", "author": "Suila, Heli", "date": "2014-05-16", "distinctwords": 3806}